Navigation Links
Touch Bionics acquires LIVINGSKIN
Date:5/15/2008

Company secures global supply of top-quality custom cosmesis, hires U.S.

sales and marketing executive

NEWBURGH, NY, USA and LIVINGSTON, Scotland, May 15 /PRNewswire/ - Touch Bionics, developer of the i-LIMB Hand, the world's first commercially available, multi-articulating bionic hand, today announced that it has acquired the complete operations of LIVINGSKIN, the developer of the unique and lifelike prosthetic skin that Touch Bionics supplies with its ground-breaking product. The acquisition will allow Touch Bionics to fulfill growing customer demand from across the world, while applying its commercial and technical expertise into new cosmesis solutions for multi-articulating hands and digits.

In addition, the acquisition of LIVINGSKIN's operations (Aesthetic Concerns Prosthetics, Inc.) provides Touch Bionics with an established physical presence in North America from which to build on the rapid growth that it has already experienced in the region. In the U.S. alone, over 180 patients have already been fitted with the i-LIMB Hand. Touch Bionics' U.S. facility will house, production, technical support, inventory and administration to directly support its growing North American customer base.

Prosthetic and Orthotic Associates, the clinical company previously associated with LIVINGSKIN, is not included in the acquisition and continues to operate independently of the newly combined business.

"This acquisition is hugely significant for Touch Bionics as we are acquiring further technical and competitive advantage in the prosthetics market," said Stuart Mead, Touch Bionics CEO. "LIVINGKSIN provides the world's most advanced cosmesis for upper limb prosthetics and the i-LIMB Hand is the world's most advanced upper limb device. It's a perfect match. The acquisition of LIVINGSKIN provides us with the people, skills and facilities to secure and grow our U.S. operations and global cosmesis supply."

Representing the forefront of research and development in this area, LIVINGSKIN's products resemble human skin by simulating the three dermal layers of natural human skin. The company already supplies many of the world's leading clinics with its high-definition custom cosmesis covering and silicone restoration products, and will continue to do so.

"We have been working in close partnership with Touch Bionics for some time now, and the acquisition is a natural progression of that partnership," said Tom Passero, LIVINGSKIN president. "As part of Touch Bionics, our future is both secure and exciting. We are committed to maintaining the same level of top-quality service to our customers and partners across the world while working with the Touch Bionics team to innovate cosmesis options for users."

To finance the deal and provide further U.S. expansion funding, Touch Bionics raised additional capital through existing investors, Archangel Informal Investment, TriCap and Scottish Enterprise's Co-investment fund.

"Touch Bionics is one of the most exciting technology companies to emerge from the U.K. in recent years and we are delighted to support its growth," said John Waddell, chief executive of Archangels. "The acquisition of a leading U.S. development company in order to grow a vital area of Touch Bionics' business, and firmly establish its U.S. presence reflects the success and confidence that permeates the company."

Touch Bionics has seen a 10-fold increase in headcount over the last year and has now hired Mark Ford, formerly a director of OMEGA Tracer, a division of Ohio Willow Wood, to run Touch Bionics' U.S. sales and marketing operations.

"Mark is a great addition to our senior management team and his U.S. market experience will help us greatly in securing wider relationships with the North American O&P community," said Stuart Mead. "Our growth has been phenomenal and Mark's expertise will prove invaluable as our company matures and expands."

About Touch Bionics

Touch Bionics is a leading developer of advanced upper-limb prosthetics. In 2007, Touch Bionics brought to market the i-LIMB Hand, a first-to-market prosthetic device with five individually powered articulating digits. The company continues to develop leading-edge technologies for the treatment of patients with upper-limb deficiencies. For more information, visit http://www.touchbionics.com

About LIVINGSKIN

LIVINGSKIN makes prostheses for people with finger, hand, toe, foot and facial amputations as well as custom covers for arm and leg amputations. Every device is custom painted to match the features that are unique to each patient. With LIVINGSKIN, patients receive the most realistic aesthetic restoration available.

LIVINGSKIN has facilities in Atlanta, Boston, Chicago, Los Angeles, New York, Philadelphia and Toronto and also partners with local and regional facilities throughout North America to offer its services to patients. For more information, visit http://www.livingskin.com.

The names of actual companies or products mentioned herein may be the

trademarks of their respective owners.


'/>"/>
SOURCE TOUCH BIONICS
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Touch Bionics appoints Head of Clinical Advocacy
2. Encision Launches Next Generation of EnTouch(R) Handles for Advanced Laparoscopic Procedures
3. Touch Bionics signs U.S. distribution agreement with SPS
4. Care to Care Begins Providing Radiology Benefit Management Services to Touchstone Health
5. China Technology Appoints Deloitte Touche Tohmatsu CPA as Independent Auditor
6. Touch Bionics adds to sales, marketing, production and design teams
7. Touch Bionics expands U.S. presence to meet demand for i-LIMB Hand
8. Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
9. Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health
10. Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System
11. Beckman Coulter Acquires Rights to Hepatitis C Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for its 4th ... in San Francisco, CA. The Summit brings together current and former FDA office bearers, ... and government officials from around the world to address key issues in device compliance, ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... implantation and pregnancy rates in frozen and fresh in vitro fertilization (IVF) ... and maternal age to IVF success. , After comparing the results from the ...
(Date:10/10/2017)... ... 10, 2017 , ... Dr. Bob Harman, founder and CEO of VetStem ... The event entitled “Stem Cells and Their Regenerative Powers,” was held ... Harman, DVM, MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief ...
(Date:10/9/2017)... 9, 2017  BioTech Holdings announced today identification ... its ProCell stem cell therapy prevents limb loss ... Company, demonstrated that treatment with ProCell resulted in ... as compared to standard bone marrow stem cell ... in reduction of therapeutic effect.  ...
Breaking Biology Technology:
(Date:4/11/2017)... 2017 Research and Markets has announced the ... to their offering. ... eye tracking market to grow at a CAGR of 30.37% during ... Market 2017-2021, has been prepared based on an in-depth market analysis ... and its growth prospects over the coming years. The report also ...
(Date:4/5/2017)... -- The Allen Institute for Cell Science today announces the ... and dynamic digital window into the human cell. The ... of deep learning to create predictive models of cell ... growing suite of powerful tools. The Allen Cell Explorer ... available resources created and shared by the Allen Institute ...
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
Breaking Biology News(10 mins):